Back to Search
Start Over
Frontline Ofatumumab with Hyper-CVAD in CD20+ Acute Lymphoblastic Leukemia (ALL): Updated Results of a Phase II Trial.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; Sep2017 Supplement 2, Vol. 17, pS256-S257, 1p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 17
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 124936363
- Full Text :
- https://doi.org/10.1016/j.clml.2017.07.020